Interestingly, patients overexpressing two identified HSPs – HSPA2 and DNAJC20 exhibited longer survival, whereas overexpression of other four HSPs – HSP90AA1, CCT1, CCT2, CCT6A resulted in unfavorable prognosis for breast cancer patients. This evidence concerns the gene CCT2 and breast cancer.